id paper:paper_01602446_v54_n4_p348_Polizio
record_format dspace
spelling paper:paper_01602446_v54_n4_p348_Polizio2023-06-08T15:13:24Z Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension Angiotensin II Antihypertensive drugs Aorta Arterial pressure Oxidative stress angiotensin II heme oxygenase 1 losartan minoxidil reactive oxygen metabolite reduced nicotinamide adenine dinucleotide phosphate oxidase superoxide animal experiment animal model animal tissue arterial pressure article controlled study enzyme activity hypertension male nitrosative stress nonhuman oxidative stress priority journal protein expression rat thoracic aorta Animals Antihypertensive Agents Aorta, Thoracic Blood Pressure Disease Models, Animal Heme Oxygenase (Decyclizing) Hypertension, Renal Losartan Male Minoxidil NADPH Oxidase Oxidative Stress Rats Rats, Wistar Reactive Oxygen Species Oxidative stress produced through reactive oxygen species (ROS) enhancement is considered to play a key role in the development and maintenance of hypertension. In the vasculature, the most important source of ROS is the reduced nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase enzyme. The principal stimulus of this enzyme is angiotensin II (Ang II). However, oxidative stress seems to be present in virtually all forms of hypertension including low-renin hypertension, where the levels of Ang II are reduced. For this reason, the question is if ROS generation is induced by Ang II or it is a consequence of hypertension. We used as hypertensive model the aortic coarctated rats, which were treated with losartan or minoxidil for 7 days. Thoracic aortic segments were excised, and the NAD(P)H oxidase subunits expression, oxidative stress parameters, and heme oxygenase-1 abundance were evaluated. Hypertensive animals had an increase in the activity and expression of NAD(P)H oxidase and, as a consequence, in the oxidative stress parameters. Interestingly, either losartan or minoxidil administration blunted those parameters, indicating that arterial pressure is the key factor in the development of oxidative stress in the hypertensive aorta. We suggest that antihypertensive drug administration at the beginning of this pathology delays the oxidative stress generation, thus preventing the aggravation of this disease. Copyright © 2009 by Lippincott Williams & Wilkins. 2009 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01602446_v54_n4_p348_Polizio http://hdl.handle.net/20.500.12110/paper_01602446_v54_n4_p348_Polizio
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Angiotensin II
Antihypertensive drugs
Aorta
Arterial pressure
Oxidative stress
angiotensin II
heme oxygenase 1
losartan
minoxidil
reactive oxygen metabolite
reduced nicotinamide adenine dinucleotide phosphate oxidase
superoxide
animal experiment
animal model
animal tissue
arterial pressure
article
controlled study
enzyme activity
hypertension
male
nitrosative stress
nonhuman
oxidative stress
priority journal
protein expression
rat
thoracic aorta
Animals
Antihypertensive Agents
Aorta, Thoracic
Blood Pressure
Disease Models, Animal
Heme Oxygenase (Decyclizing)
Hypertension, Renal
Losartan
Male
Minoxidil
NADPH Oxidase
Oxidative Stress
Rats
Rats, Wistar
Reactive Oxygen Species
spellingShingle Angiotensin II
Antihypertensive drugs
Aorta
Arterial pressure
Oxidative stress
angiotensin II
heme oxygenase 1
losartan
minoxidil
reactive oxygen metabolite
reduced nicotinamide adenine dinucleotide phosphate oxidase
superoxide
animal experiment
animal model
animal tissue
arterial pressure
article
controlled study
enzyme activity
hypertension
male
nitrosative stress
nonhuman
oxidative stress
priority journal
protein expression
rat
thoracic aorta
Animals
Antihypertensive Agents
Aorta, Thoracic
Blood Pressure
Disease Models, Animal
Heme Oxygenase (Decyclizing)
Hypertension, Renal
Losartan
Male
Minoxidil
NADPH Oxidase
Oxidative Stress
Rats
Rats, Wistar
Reactive Oxygen Species
Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension
topic_facet Angiotensin II
Antihypertensive drugs
Aorta
Arterial pressure
Oxidative stress
angiotensin II
heme oxygenase 1
losartan
minoxidil
reactive oxygen metabolite
reduced nicotinamide adenine dinucleotide phosphate oxidase
superoxide
animal experiment
animal model
animal tissue
arterial pressure
article
controlled study
enzyme activity
hypertension
male
nitrosative stress
nonhuman
oxidative stress
priority journal
protein expression
rat
thoracic aorta
Animals
Antihypertensive Agents
Aorta, Thoracic
Blood Pressure
Disease Models, Animal
Heme Oxygenase (Decyclizing)
Hypertension, Renal
Losartan
Male
Minoxidil
NADPH Oxidase
Oxidative Stress
Rats
Rats, Wistar
Reactive Oxygen Species
description Oxidative stress produced through reactive oxygen species (ROS) enhancement is considered to play a key role in the development and maintenance of hypertension. In the vasculature, the most important source of ROS is the reduced nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase enzyme. The principal stimulus of this enzyme is angiotensin II (Ang II). However, oxidative stress seems to be present in virtually all forms of hypertension including low-renin hypertension, where the levels of Ang II are reduced. For this reason, the question is if ROS generation is induced by Ang II or it is a consequence of hypertension. We used as hypertensive model the aortic coarctated rats, which were treated with losartan or minoxidil for 7 days. Thoracic aortic segments were excised, and the NAD(P)H oxidase subunits expression, oxidative stress parameters, and heme oxygenase-1 abundance were evaluated. Hypertensive animals had an increase in the activity and expression of NAD(P)H oxidase and, as a consequence, in the oxidative stress parameters. Interestingly, either losartan or minoxidil administration blunted those parameters, indicating that arterial pressure is the key factor in the development of oxidative stress in the hypertensive aorta. We suggest that antihypertensive drug administration at the beginning of this pathology delays the oxidative stress generation, thus preventing the aggravation of this disease. Copyright © 2009 by Lippincott Williams & Wilkins.
title Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension
title_short Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension
title_full Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension
title_fullStr Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension
title_full_unstemmed Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension
title_sort lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension
publishDate 2009
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01602446_v54_n4_p348_Polizio
http://hdl.handle.net/20.500.12110/paper_01602446_v54_n4_p348_Polizio
_version_ 1768543272652767232